{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:31:38Z","timestamp":1768566698954,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdsjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.jdermsci.2015.05.003","type":"journal-article","created":{"date-parts":[[2015,5,20]],"date-time":"2015-05-20T01:56:28Z","timestamp":1432086988000},"page":"163-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Treatment with low-dose cytokines reduces oxidative-mediated injury in perilesional keratinocytes from vitiligo skin"],"prefix":"10.1016","volume":"79","author":[{"given":"Victoria","family":"Barygina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Becatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torello","family":"Lotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niccol\u00f2","family":"Taddei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Fiorillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jdermsci.2015.05.003_bib0190","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","article-title":"Vitiligo: a comprehensive overview, Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up","volume":"65","author":"Alikhan","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jdermsci.2015.05.003_bib0195","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1590\/abd1806-4841.20142573","article-title":"Vitiligo\u2014Part 1","volume":"89","author":"Tarl\u00e9","year":"2014","journal-title":"An Bras Dermatol"},{"issue":"4","key":"10.1016\/j.jdermsci.2015.05.003_bib0200","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/exd.12103","article-title":"Vitiligo: interplay between oxidative stress and immune system","volume":"22","author":"Laddha","year":"2013","journal-title":"Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jdermsci.2015.05.003_bib0205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.autrev.2014.10.002","article-title":"Regulatory T cells in vitiligo: implications for pathogenesis and therapeutics","volume":"14","author":"Dwivedi","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.jdermsci.2015.05.003_bib0210","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.autrev.2011.02.004","article-title":"Immunopathogenesis of vitiligo","volume":"10","author":"Sandoval-Cruz","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jdermsci.2015.05.003_bib0215","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.immuni.2006.06.002","article-title":"Th17: an effector CD4T cell lineage with regulatory T cell ties","volume":"24","author":"Weaver","year":"2006","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.jdermsci.2015.05.003_bib0220","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2230.2010.03972.x","article-title":"Role of interleukin-17 in the pathogenesis of vitiligo","volume":"36","author":"Bassiouny","year":"2011","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.jdermsci.2015.05.003_bib0225","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jdermsci.2009.02.004","article-title":"Ultrastructural and functional alterations of mitochondria in PL vitiligo skin","volume":"54","author":"Prignano","year":"2009","journal-title":"J Dermatol Sci"},{"issue":"9","key":"10.1016\/j.jdermsci.2015.05.003_bib0230","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1089\/ars.2009.2779","article-title":"The involvement of Smac\/DIABLO, p53, NF-kB, and MAPK pathways in apoptosis of keratinocytes from perilesional vitiligo skin: Protective effects of curcumin and capsaicin","volume":"13","author":"Becatti","year":"2010","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"10.1016\/j.jdermsci.2015.05.003_bib0235","first-page":"133","article-title":"Immunomodulating treatment with low dose interleukin-4, interleukin-10 and interleukin-11 in psoriasis vulgaris","volume":"28","author":"Roberti","year":"2014","journal-title":"J Biol Regul Homeost Agents"},{"issue":"1","key":"10.1016\/j.jdermsci.2015.05.003_bib0240","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.intimp.2013.12.011","article-title":"Low-doses of sequential-kinetic-activated interferon-\u03b3 enhance the ex vivo cytotoxicity of peripheral blood natural killer cells from patients with early-stage colorectal cancer. A preliminary study","volume":"19","author":"Radice","year":"2014","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10.1016\/j.jdermsci.2015.05.003_bib0245","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4236\/jct.2012.324044","article-title":"Low dose of IL-12 stimulates T cell response in cultures of PBMCs derived from non small cell lung cancer patients","volume":"3","author":"D\u2019Amico","year":"2012","journal-title":"J Cancer Ther"},{"issue":"5 Pt 1","key":"10.1016\/j.jdermsci.2015.05.003_bib0250","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0190-9622(92)70094-V","article-title":"Plasma alpha-melanocyte-stimulating hormone, beta-endorphin, met-enkephalin, and natural killer cell activity in vitiligo","volume":"26","author":"Mozzanica","year":"1992","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jdermsci.2015.05.003_bib0255","first-page":"493","article-title":"Sodium ascorbate and basic fibroblast growth factor protect muscle-derived cells from H2O2-induced oxidative stress","volume":"56","author":"Burdzi\u0144ska","year":"2006","journal-title":"Comp Med"},{"key":"10.1016\/j.jdermsci.2015.05.003_bib0260","first-page":"385","article-title":"Assay of mitochondrial functions by resazurin in vitro","volume":"25","author":"Zhang","year":"2004","journal-title":"Acta Pharmacol Sin"},{"issue":"15","key":"10.1016\/j.jdermsci.2015.05.003_bib0265","doi-asserted-by":"crossref","first-page":"13304","DOI":"10.1074\/jbc.M110.192138","article-title":"The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4","volume":"286","author":"Takac","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jdermsci.2015.05.003_bib0270","series-title":"Pigmentary disorders: a comprehensive compendium","first-page":"1","article-title":"History and evolution of pigmentary disorders in human","author":"Kumar Mukhopadhyay","year":"2014"},{"issue":"3","key":"10.1016\/j.jdermsci.2015.05.003_bib0275","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.clindermatol.2013.11.011","article-title":"Vitiligo as a systemic disease","volume":"32","author":"Lotti","year":"2014","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jdermsci.2015.05.003_bib0280","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/jid.2011.321","article-title":"Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis","volume":"132","author":"Spritz","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jdermsci.2015.05.003_bib0285","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.jid.5700538","article-title":"Oxidative stress via hydrogen peroxide affects proopiomelanocortin peptides directly in the epidermis of patients with vitiligo","volume":"127","author":"Spencer","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2015.05.003_bib0290","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.anndiagpath.2014.01.002","article-title":"Immunohistochemical expression of aberrant Notch-1 signalling in vitiligo: an implication for pathogenesis","volume":"18","author":"Seleit","year":"2014","journal-title":"Ann Diagn Pathol"},{"issue":"7","key":"10.1016\/j.jdermsci.2015.05.003_bib0295","first-page":"849","article-title":"Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis","volume":"24","author":"Moretti","year":"2009","journal-title":"Histol Histopathol"},{"issue":"6","key":"10.1016\/j.jdermsci.2015.05.003_bib0300","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4103\/0019-5154.143506","article-title":"Can systemically generated reactive oxygen species help to monitor disease activity in generalized vitiligo?. A pilot study","volume":"59","author":"Pradhan","year":"2014","journal-title":"Indian J Dermatol"},{"issue":"4","key":"10.1016\/j.jdermsci.2015.05.003_bib0305","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4103\/2229-5178.120637","article-title":"Study of oxidative stress in peripheral blood of Indian vitiligo patients","volume":"4","author":"Deo","year":"2013","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jdermsci.2015.05.003_bib0310","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/1523-1747.ep12335801","article-title":"Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo","volume":"109","author":"Maresca","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2015.05.003_bib0315","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/exd.12151","article-title":"Commentary from the editorial board to vitiligo: interplay between oxidative stress and immune system (Laddha et al.)","volume":"22","author":"Colucci","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jdermsci.2015.05.003_bib0320","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1600-0749.2007.00399.x","article-title":"Vitiligo puzzle: the pieces fall in place","volume":"20","author":"Westerhof","year":"2007","journal-title":"Pigment Cell Res"},{"issue":"4","key":"10.1016\/j.jdermsci.2015.05.003_bib0325","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.autrev.2014.12.003","article-title":"Why treatments do(n\u2019t) work in vitiligo: an autoinflammatory perspective","volume":"14","author":"Speeckaert","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.jdermsci.2015.05.003_bib0330","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.jidsp.5640189","article-title":"In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase","volume":"4","author":"Schallreuter","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"6","key":"10.1016\/j.jdermsci.2015.05.003_bib0335","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1096\/fj.11-197137","volume":"26","author":"Schallreuter","year":"2012","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.jdermsci.2015.05.003_bib0340","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1096\/fj.11-201897","volume":"26","author":"Schallreuter","year":"2012","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.jdermsci.2015.05.003_bib0345","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.0022-202X.2004.22410.x","article-title":"A constitutive NADPH oxidase-like system containing gp91phox homologs in human keratinocytes","volume":"122","author":"Chamulitrat","year":"2004","journal-title":"J Invest Dermatol"},{"issue":"Pt 2","key":"10.1016\/j.jdermsci.2015.05.003_bib0350","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1042\/bj3070549","article-title":"Antagonistic effects of different members of the fibroblast and platelet-derived growth factor families on adipose conversion and NADPH-dependent H2O2 generation in 3T3 L1-cells","volume":"307","author":"Krieger-Brauer","year":"1995","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.jdermsci.2015.05.003_bib0355","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0923-1811(00)00156-0","article-title":"Levels of beta-endorphin in the plasma and skin tissue fluids of patients with vitiligo","volume":"26","author":"Caixia T1","year":"2001","journal-title":"J Dermatol Sci"},{"issue":"3","key":"10.1016\/j.jdermsci.2015.05.003_bib0360","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.185.3.415","article-title":"Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses","volume":"185","author":"Marinaro","year":"1997","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.jdermsci.2015.05.003_bib0365","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2460\/ajvr.2005.66.164","article-title":"Systemic effect of interferons after oral administration in animals and humans","volume":"66","author":"Cummins","year":"2005","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.jdermsci.2015.05.003_bib0370","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/jaut.1996.0003","article-title":"Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis","volume":"9","author":"Brod","year":"1996","journal-title":"J Autoimmun"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181115001681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181115001681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T03:27:49Z","timestamp":1717903669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181115001681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0923181115001681"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2015.05.003","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with low-dose cytokines reduces oxidative-mediated injury in perilesional keratinocytes from vitiligo skin","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2015.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}